Social Anxiety Telehealth Therapy Study
Status
Conditions
Treatments
Details and patient eligibility
About
The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age 18+,
- Liebowitz Social Anxiety Scale (LSAS) total score > 50
- Fluent spoken and written English
- Access to the internet via a smartphone or computer with a camera
- Ability to provide informed consent.
Exclusion criteria
- History of mania or psychosis
- Moderate or severe substance use disorder within the past year
- Current psychiatric diagnosis of greater impairment than that arising from social anxiety
- High risk for suicide (>8 on the Mini International Neuropsychiatric Interview suicidality section)
- Prior exposure therapy (more than 2 sessions)
- Current psychotropic medication use
- Current psychotherapy other than couples counseling.
Trial design
Primary purpose
Allocation
Interventional model
Masking
26 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal